PRIMA Gains Approval from European Medical Device Regulatory Authority, Offering Hope to Restore Vision for Blind Patients
4 day ago / Read about 0 minute
Author:小编   

Science Corporation, a brain-computer interface company, has recently made a significant leap forward. Its implantable device, PRIMA, designed to restore vision, has secured approval from European medical device regulatory bodies, paving the way for its sale across the European market. This device is primarily intended for patients suffering from vision impairment caused by age-related macular degeneration. Through the implantation of a microchip at the back of the eye and the utilization of specialized glasses, PRIMA effectively circumvents damaged photoreceptor cells, stimulates retinal nerve cells, and transmits visual signals to the brain, thereby assisting patients in regaining functional vision.